Evidence map›Paper›PMID 42744380›Full record

ArticleBMJ open2026

Pilot feasibility study to deliver low-dose CT lung cancer screening in Scotland: descriptive findings from the LungScot study.

Debbie Cavers, Ahsan R Akram, Elizabeth K Sage, John D Maclay, Gordon W Cowell, James Mitchell, Graeme Dickie, Christine Campbell, Kathryn A Robb, Frank Sullivan and 5 more

Abstract readMulticenter Study
In one paragraph

Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Debbie CaversUsher Institute, University of Edinburgh, Edinburgh, UK debbie.cavers@ed.ac.uk.ORCID http://orcid.org/0000-0002-5419-6331
Ahsan R AkramCentre for Inflammation Research, The University of Edinburgh The Queen's Medical Research Institute, Edinburgh, UK.
Elizabeth K SageRespiratory Medicine, NHS Highland, Inverness, UK.ORCID http://orcid.org/0000-0002-9009-421X
John D MaclayGlasgow Royal Infirmary, NHS Greater Glasgow and Clyde, Glasgow, UK.
Gordon W CowellSchool of Health and Wellbeing, University of Glasgow, Glasgow, UK.
James MitchellRespiratory Medicine, Aberdeen Royal Infirmary, NHS Grampian, Aberdeen, UK.
Graeme DickieBeatson West of Scotland Cancer Centre, Glasgow, UK.
Christine CampbellUsher Institute, University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0003-4868-0554
Kathryn A RobbSchool of Health and Wellbeing, University of Glasgow, Glasgow, UK.ORCID http://orcid.org/0000-0002-1672-0411
Frank SullivanUniversity of St. Andrews, St Andrews, UK.ORCID http://orcid.org/0000-0002-6623-4964
Peter MurchieDivision of Applied Health Science, University of Aberdeen, Aberdeen, UK.ORCID http://orcid.org/0000-0001-9968-5991
Aileen NeilsonEdinburgh Clinical Trials Unit (ECTU), Usher Institute, The University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0003-3758-0566
Robert J C SteeleUniversity of Dundee, Dundee, UK.
Edwin J R van BeekInstitute for Neuroscience and Cardiovascular Research, University of Edinburgh, Edinburgh, UK.
David WellerUsher Institute, University of Edinburgh, Edinburgh, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo assess the feasibility and acceptability of delivering risk-stratified low-dose CT (LDCT) lung cancer screening across diverse geographical and socioeconomic settings in Scotland and to characterise uptake, participant profile and screening outcomes.

designProspective, multicentre pilot feasibility study with descriptive analysis.

settingPrimary and secondary care interface across four regional Health Boards in Scotland, encompassing urban, rural, remote and socioeconomically deprived populations.

participants2801 individuals aged 50-74 years, identified from primary care electronic medical records (EMRs), with a history of smoking were invited (current or within 15 years where available); 668 (23.8%) responded. Of 608 assessed for eligibility (50.8% female; median age 63 years), 503 (82.7%) met at least one predefined high-risk criterion.

interventionsInvitation to a lung health check, followed by telephone-based risk assessment using US Preventative Services Task Force, Liverpool Lung Pathway version 2 and the Prostate, Lung, Colorectal and Ovarian Screening Trial criteria. High-risk participants were offered a one-off LDCT scan at local centres. PRIMARY AND SECONDARY OUTCOME MEASURES: Primary: feasibility indicators including uptake, risk eligibility and scan completion. Secondary: prevalence of lung cancer, pulmonary nodules and incidental findings (eg, coronary artery disease, emphysema).

resultsResponse rate was 23.8% (668/2801), varying from 17.8% to 38.1% across practices and lower in more deprived areas. Of 503 eligible participants, 436 (86.7%) underwent LDCT. Abnormal findings were present in 83.3% of scans. Lung nodules were detected in 25.7% (112/436), with 11.8% requiring follow-up. Lung cancer was diagnosed in 1.15% (5/436; 95%), alongside five additional malignancies. Coronary artery disease was identified in 56.4% (246/436) and emphysema in 33% (144/436). Non-responders were more likely to be current smokers (69.3% vs 49.8%).

conclusionsRecruitment of people for lung cancer screening using the smoking history recorded in their primary care EMR is feasible. This approach identifies a high-risk population with a high burden of both malignant and non-malignant disease, and with substantial undiagnosed disease burden. However, uptake was modest and socially patterned, highlighting the need for equity-focused implementation strategies, including repeated invitations and targeted engagement. These findings are particularly relevant as Scotland considers implementation of a national lung cancer screening programme within a health system characterised by marked geographical and socioeconomic inequalities. Further research should evaluate long-term outcomes, cost-effectiveness and strategies to improve equitable participation.

Indexed as

Early Detection of CancerLung NeoplasmsTomography, X-Ray ComputedAgedFeasibility StudiesFemaleHumansMaleMass ScreeningMiddle AgedPilot ProjectsProspective StudiesRadiation DosageRisk AssessmentScotlandSmokingLung NeoplasmsMass ScreeningRADIOLOGY & IMAGING

Identifiers

PMID42744380
PMCPMC13583738

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.